Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals.

BACKGROUND: Both in clinical routine and in preclinical research, the established standard procedure for the final purification of radiometal-labeled peptide radiopharmaceuticals is cartridge-based reversed-phase (RP) solid phase extraction (SPE). It allows the rapid and quantitative separation of the radiolabeled peptide from hydrophilic impurities and easy integration into automated synthesis procedures. However, product elution from RP cartridges necessitates the use of organic solvents and product recovery is sometimes limited. Thus, an alternative purification method based on commercially available size exclusion cartridges was investigated. RESULTS: Since most peptide radiopharmaceuticals have a molecular weight > 1 kDa, Sephadex G10 cartridges with a molecular size cut-off of 700 Da were used for the final purification of a broad palette of 68Ga-, 64Cu- and 99mTc-labeled experimental peptide radiotracers as well as the clinically relevant ligand PSMA-617. Results (radiochemical purity (RCP, determined by ITLC), recovery from the solid support) were compared to the respective standard RP-SPE method. Generally, retention of unreacted 68Ga, 64Cu and 99mTc salts on the G10 cartridges was quantitative up to the specified elution volume (1.2 mL) for 68Ga and 99mTc and 99.6% for 64Cu. Even at increased elution volumes of 1.5-2 mL, RCPs of the eluted 68Ga- and 99mTc -radiopeptides were > 99%. For all peptides with a molecular weight ≥ 2 kDa, product recovery from the G10 cartridges was consistently > 85% upon respective adjustment of the elution volume. Product recovery was lowest for [68Ga]Ga-PSMA-617 (67%, 1.2 mL to 84%, 2 mL). The pH of the final product solution was found to be volume-dependent (1.2 mL: pH 6.3; 1.5 mL: pH 5.9; 2 mL: pH 5.5). Notably, the G10 cartridges were reused up to 20 times without compromising performance, and implementation of the method in an automated radiosynthesis procedure was successful. CONCLUSIONS: Overall, size exclusion purification yielded all peptide radiopharmaceuticals in excellent radiochemical purities (> 99%) in saline within 10-12 min. Although product recovery is marginally inferior to classical SPE purifications, this method has the advantage of completely avoiding organic solvents and representing a cost-effective, easy-to-implement purification approach for automated radiotracer synthesis.

Mechanism of Reduction of Aqueous U(V)-dpaea and Solid-Phase U(VI)-dpaea Complexes: The Role of Multiheme c-Type Cytochromes.

The biological reduction of soluble U(VI) complexes to form immobile U(IV) species has been proposed to remediate contaminated sites. It is well established that multiheme c-type cytochromes (MHCs) are key mediators of electron transfer to aqueous phase U(VI) complexes for bacteria such as Shewanella oneidensis MR-1. Recent studies have confirmed that the reduction proceeds via a first electron transfer forming pentavalent U(V) species that readily disproportionate. However, in the presence of the stabilizing aminocarboxylate ligand, dpaea2- (dpaeaH2═bis(pyridyl-6-methyl-2-carboxylate)-ethylamine), biologically produced U(V) persisted in aqueous solution at pH 7. We aim to pinpoint the role of MHC in the reduction of U(V)-dpaea and to establish the mechanism of solid-phase U(VI)-dpaea reduction. To that end, we investigated U-dpaea reduction by two deletion mutants of S. oneidensis MR-1-one lacking outer membrane MHCs and the other lacking all outer membrane MHCs and a transmembrane MHC-and by the purified outer membrane MHC, MtrC. Our results suggest that solid-phase U(VI)-dpaea is reduced primarily by outer membrane MHCs. Additionally, MtrC can directly transfer electrons to U(V)-dpaea to form U(IV) species but is not strictly necessary, underscoring the primary involvement of outer membrane MHCs in the reduction of this pentavalent U species but not excluding that of periplasmic MHCs.

The mechanism of Fe induced bond stability of uranyl(v).

The stabilization of uranyl(v) (UO2 1 + ) by Fe(ii) in natural systems remains an open question in uranium chemistry. Stabilization of UVO2 1+ by Fe(ii) against disproportionation was also demonstrated in molecular complexes. However, the relation between the Fe(ii) induced stability and the change of the bonding properties have not been elucidated up to date. We demonstrate that U(v) - oaxial bond covalency decreases upon binding to Fe(ii) inducing redirection of electron density from the U(v) - oaxial bond towards the U(v) - equatorial bonds thereby increasing bond covalency. Our results indicate that such increased covalent interaction of U(v) with the equatorial ligands resulting from iron binding lead to higher stability of uranyl(v). For the first time a combination of U M4,5 high energy resolution X-ray absorption near edge structure (HR-XANES) and valence band resonant inelastic X-ray scattering (VB-RIXS) and ab initio multireference CASSCF and DFT based computations were applied to establish the electronic structure of iron-bound uranyl(v).

Biological Reduction of a U(V)-Organic Ligand Complex.

Metal-reducing microorganisms such as Shewanella oneidensis MR-1 reduce highly soluble species of hexavalent uranyl (U(VI)) to less mobile tetravalent uranium (U(IV)) compounds. The biologically mediated immobilization of U(VI) is being considered for the remediation of U contamination. However, the mechanistic underpinnings of biological U(VI) reduction remain unresolved. It has become clear that a first electron transfer occurs to form pentavalent (U(V)) intermediates, but it has not been definitively established whether a second one-electron transfer can occur or if disproportionation of U(V) is required. Here, we utilize the unusual properties of dpaea2- ((dpaeaH2═bis(pyridyl-6-methyl-2-carboxylate)-ethylamine)), a ligand forming a stable soluble aqueous complex with U(V), and investigate the reduction of U(VI)-dpaea and U(V)-dpaea by S. oneidensis MR-1. We establish U speciation through time by separating U(VI) from U(IV) by ion exchange chromatography and characterize the reaction end-products using U M4-edge high resolution X-ray absorption near-edge structure (HR-XANES) spectroscopy. We document the reduction of solid phase U(VI)-dpaea to aqueous U(V)-dpaea but, most importantly, demonstrate that of U(V)-dpaea to U(IV). This work establishes the potential for biological reduction of U(V) bound to a stabilizing ligand. Thus, further work is warranted to investigate the possible persistence of U(V)-organic complexes followed by their bioreduction in environmental systems.

Synthesis and Characterization of Water Stable Uranyl(V) Complexes.

The importance of uranyl(V) (UO2 + ) species associated with environmental and geologic applications is becoming increasingly evident, but the tendency of the uranyl(V) cation to disproportionate in water has prevented the isolation of stable complexes. Here we demonstrate that in the presence of the tridentate complexing dipicolinate (dpa2- ), a ligand highly abundant in soil, the uranyl(V) species can be stabilized and isolated in anoxic basic water. Stable uranyl(V) dipicolinate complexes are readily formed from the reduction of the uranyl(VI) analogue both in organic solution and in basic water, and their solution and solid-state structure were determined. A bis-dpa UV O2 + complex was obtained from water at pH 10, while at higher pH values, a trinuclear mono-dpa cation-cation complex was isolated. These results present the second ever isolated water stable uranyl(V) complex. Moreover, we demonstrate that dipicolinate complexes of UVI O2 2+ , UV O2 + and UIV are strongly luminescent with a signature characteristic of each oxidation state. This provides unique examples of luminescent UV and UIV compounds.

Ligand-Supported Facile Conversion of Uranyl(VI) into Uranium(IV) in Organic and Aqueous Media.

Reduction of uranyl(VI) to UV and to UIV is important in uranium environmental migration and remediation processes. The anaerobic reduction of a uranyl UVI complex supported by a picolinate ligand in both organic and aqueous media is presented. The [UVI O2 (dpaea)] complex is readily converted into the cis-boroxide UIV species via diborane-mediated reductive functionalization in organic media. Remarkably, in aqueous media the uranyl(VI) complex is rapidly converted, by Na2 S2 O4 , a reductant relevant for chemical remediation processes, into the stable uranyl(V) analogue, which is then slowly reduced to yield a water-insoluble trinuclear UIV oxo-hydroxo cluster. This report provides the first example of direct conversion of a uranyl(VI) compound into a well-defined molecular UIV species in aqueous conditions.

Structural Snapshots of Cluster Growth from {U6 } to {U38 } During the Hydrolysis of UCl4.

Herein we report the assembly of large uranium(IV) clusters with novel nuclearities and/or shapes from the controlled hydrolysis of UCl4 in organic solution and in the presence of the benzoate ligands. {U6 }, {U13 }, {U16 }, {U24 }, {U38 } oxo and oxo/hydroxo clusters were isolated and crystallographically characterized. These structural snapshots indicate that larger clusters are slowly built from the condensation of octahedral {U6 } building blocks. The uranium/benzoate ligand ratio, the reaction temperature and the presence of base play an important role in determining the structure of the final assembly. Moreover, the isolation of different size cluster {U6 } (few hours), {U16 } (3 days), {U24 } (21 days) from the same solution in a chosen set of conditions shows that the assembly of uranium oxo clusters in hydrolytic conditions is time dependent.

Synthesis and Characterization of a Water Stable Uranyl(V) Complex.

We have identified a polydentate aminocarboxylate ligand that stabilizes uranyl(V) in water. The mononuclear [UO2(dpaea)]X, (dpaeaH2 = Bis(pyridyl-6-methyl-2-carboxylate)-ethylamine; X = CoCp2*+ or X = K(2.2.2.cryptand) complexes have been isolated from anaerobic organic solution, crystallographically and spectroscopically characterized both in water and organic solution. These complexes disproportionate at pH ≤ 6, but are stable in anaerobic water at pH 7-10 for several days.

The effect of iron binding on uranyl(v) stability.

Here we report the effect of UO2 +···Fe2+ cation-cation interactions on the redox properties of uranyl(v) complexes and on their stability with respect to proton induced disproportionation. The tripodal heptadentate Schiff base trensal3- ligand allowed the synthesis and characterization of the uranyl(vi) complexes [UO2(trensal)K], 1 and [UO2(Htrensal)], 2 and of uranyl(v) complexes presenting UO2 +···K+ or UO2 +···Fe2+ cation-cation interactions ([UO2(trensal)K]K, 3, [UO2(trensal)] [K(2.2.2crypt)][K(2.2.2crypt)], 4, [UO2(trensal)Fe(py)3], 6). The uranyl(v) complexes show similar stability in pyridine solution, but the presence of Fe2+ bound to the uranyl(v) oxygen leads to increased stability with respect to proton induced disproportionation through the formation of a stable Fe2+-UO2 +-U4+ intermediate ([UO2(trensal)Fe(py)3U(trensal)]I, 7) upon addition of 2 eq. of PyHCl to 6. The addition of 2 eq. of PyHCl to 3 results in the immediate formation of U(iv) and UO2 2+ compounds. The presence of an additional UO2 + bound Fe2+ in [(UO2(trensal)Fe(py)3)2Fe(py)3]I2, 8, does not lead to increased stability. Redox reactivity and cyclic voltammetry studies also show an increased range of stability of the uranyl(v) species in the presence of Fe2+ with respect both to oxidation and reduction reactions, while the presence of a proton in complex 2 results in a smaller stability range for the uranyl(v) species. Cyclic voltammetry studies also show that the presence of a Fe2+ cation bound through one trensal3- arm in the trinuclear complex [{UO2(trensal)}2Fe], 5 does not lead to increased redox stability of the uranyl(v) showing the important role of UO2 +···Fe2+ cation-cation interactions in increasing the stability of uranyl(v). These results provide an important insight into the role that iron binding may play in stabilizing uranyl(v) compounds in the environmental mineral-mediated reduction of uranium(vi).

A practical and catalyst-free trifluoroethylation reaction of amines using trifluoroacetic acid.

Amines are a fundamentally important class of biologically active compounds and the ability to manipulate their physicochemical properties through the introduction of fluorine is of paramount importance in medicinal chemistry. Current synthesis methods for the construction of fluorinated amines rely on air and moisture sensitive reagents that require special handling or harsh reductants that limit functionality. Here we report practical, catalyst-free, reductive trifluoroethylation reactions of free amines exhibiting remarkable functional group tolerance. The reactions proceed in conventional glassware without rigorous exclusion of either moisture or oxygen, and use trifluoroacetic acid as a stable and inexpensive fluorine source. The new methods provide access to a wide range of medicinally relevant functionalized tertiary ß-fluoroalkylamine cores, either through direct trifluoroethylation of secondary amines or via a three-component coupling of primary amines, aldehydes and trifluoroacetic acid. A reduction of in situ-generated silyl ester species is proposed to account for the reductive selectivity observed.